✦ LIBER ✦

Limitations of metformin use in patients with kidney disease: are they warranted?

✍ Scribed by K. P. Vasisht; S.-C. Chen; Y. Peng; G. L. Bakris

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fibroblast Growth Factor 23 and Matrix-M

✍ Peiskerová, M.; Kalousová, M.; Kratochvílová, M.; Du 📂 Article 📅 2009 🏛 S. Karger AG 🌐 English ⚖ 341 KB

Use of Enoxaparin in Patients with Chron

✍ Dr Donald F. Brophy, Domenic A. Sica 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 67 KB

Use of Antiepileptic Drugs in Patients w

✍ Rubeen K. Israni; Nishaminy Kasbekar; Kevin Haynes; Jeffrey S. Berns 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Drug-eluting stents in patients with sta

✍ Luis Gruberg; William E. Lawson; Allen Jeremias; Anil Mani; Joseph Chernilas; Li 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Erythrocyte metformin levels in patients

✍ Briet, C.; Saraval-Gross, M.; Kajbaf, F.; Fournier, A.; Hary, L.; Lalau, J.-D. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 74 KB

Longitudinal ANCA measurements for predi

✍ Kemna, M.; Damoiseaux, J.; Austen, J.; Winkens, B.; Peters, J.; Van Paassen, P.; 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 67 KB